Carole Kuehl-Mannetho wrote -
On Sunday, June 23, hundreds of teammates will come together to run the 2019 Boston Athletic Association’s (B.A.A.) 10K® road race to support Brigham and Women’s Hospital (BWH) and Brigham and Women’s Faulkner Hospital (BWFH ).
The Waldor lab at Brigham and Women's Hospital, is developing a ground-breaking oral cholera vaccine called HaitiV (see Hubbard et al. Science Translational Medicine 13 Jun 2018: Vol. 10, Issue 445).
The vaccine acts as a fast-acting probiotic that decreases Vibrio cholerae infection from taking hold as well as a traditional vaccine, which educates the immune system inducing production of antibodies that kill Vibrio cholerae bacteria (Sit et al. BioRxiv.org Feb 2019).
This fast-acting vaccine promises to revolutionize cholera outbreak control.
The Waldor Lab at BWH is planning a Phase I clinical trial to test this new vaccine in human volunteers.
By supporting team Cholera Crushers in the BAA 10K fundraiser, YOU can help fund our Phase I clinical trial! Money our team raises will go directly to Dr. Waldor's general research fund at BWH and will be used to produce the vaccine doses for the trial.